Physician profile
Krista J Stapleton
NPI 1275772055
$5,282.99
in general payments reported to CMS, 2019-2025
15 companies · $1,782 in 2025
The $1,782 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $334 · 2021: $1,540 · 2022: $349 · 2023: $488 · 2024: $585 · 2025: $1,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,737 · Travel and Lodging: $950 · Entertainment: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.04 |
| Travel and Lodging | $950.29 |
| Entertainment | $167.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,907.80 | 2019-2025 | Total30, Precision7 |
| Coopervision INC. | $219.56 | 2021-2024 | Myday Contact Lens, Biofinity Contact Lens |
| Amgen INC. | $200.65 | 2024-2025 | Tepezza |
| Optos, INC. | $181.57 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $169.13 | 2020-2023 | Cequa |
| Topcon Healthcare, INC. | $163.22 | 2024 | |
| Horizon Therapeutics Plc | $98.48 | 2023 | Tepezza |
| Abb Con-Cise Optical Group LLC | $84.23 | 2025 | Contact Lens |
| Novartis Pharmaceuticals Corporation | $52.66 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.50 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $45.01 | 2021-2023 | Acuvue |
| Biotissue Holdings INC. | $37.96 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $24.87 | 2024 | Xdemvy |
| Abbvie INC. | $24.20 | 2022 | |
| Bausch & Lomb Americas INC. | $21.15 | 2025 | Infuse, Biotrue One Day |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.